Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Cascadian Therapeutics, Inc. | Financial_Report.xls |
EX-31.2 - EX-31.2 - Cascadian Therapeutics, Inc. | d884239dex312.htm |
EX-31.1 - EX-31.1 - Cascadian Therapeutics, Inc. | d884239dex311.htm |
EX-32.1 - EX-32.1 - Cascadian Therapeutics, Inc. | d884239dex321.htm |
EX-32.2 - EX-32.2 - Cascadian Therapeutics, Inc. | d884239dex322.htm |
EX-23.1 - EX-23.1 - Cascadian Therapeutics, Inc. | d884239dex231.htm |
EX-10.1 - EX-10.1 - Cascadian Therapeutics, Inc. | d884239dex101.htm |
EX-10.26 - EX-10.26 - Cascadian Therapeutics, Inc. | d884239dex1026.htm |
10-K - FORM 10-K - Cascadian Therapeutics, Inc. | d884239d10k.htm |
EX-10.2 - EX-10.2 - Cascadian Therapeutics, Inc. | d884239dex102.htm |
Exhibit 21.1
SUBSIDIARIES OF ONCOTHYREON INC.
Name of Subsidiary | Jurisdiction of Incorporation | |
Oncothyreon Canada ULC | Alberta | |
Biomira Management, Inc. | Delaware | |
ProlX Pharmaceuticals Corporation | Delaware | |
Biomira B.V. | Netherlands | |
0811769 B.C. ULC | British Columbia | |
Oncothyreon Luxembourg s.a.r.l. Protocell Therapeutics Inc. |
Luxembourg Delaware |